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Abstract: The aim of this article is to study the changes inhibited T lymphocytes and cytokines 
related to the cellular immunity in ICR (imprinting control region) mice fed with Fe3O4 magnetic 
nanoparticles (Fe3O4-MNPs). The Fe3O4-MNPs were synthesized, and their characteristics such 
as particle size, zeta potential, and X-ray diffraction patterns were measured and determined. 
All ICR mice were sacrificed after being exposed to 0, 300, 600, and 1200 mg/kg of Fe3O4-
MNPs by single gastric administration for 14 days. Splenocytes proliferation was indicated with 
stimulate index by MTT assay; release of cytokines in the serum of ICR mice was detected by 
enzyme-linked immunosorbent assay, and the phenotypic analyses of T-lymphocyte subsets were 
performed using flow cytometry. Our results indicated that there were no significant differences 
in splenocyte proliferation and release of cytokines between exposed and control groups. 
Furthermore, there was no significant difference in the proportions of T-lymphocyte subsets in 
the low-dose Fe3O4-MNPs group when compared to the control group, but the proportions of 
CD3+CD4+ and CD3+CD8+ T-lymphocyte subsets both in the medium- and high-dose Fe3O4-
MNPs groups were higher than those in the control group. It is concluded that a high dose of 
Fe3O4-MNPs, to some extent, could influence in vivo immune function of normal ICR mice.
Keywords: Fe3O4, magnetic nanoparticles, splenocyte proliferation, release of cytokines, 
T-lymphocyte subsets, ICR mice
Introduction
Recently, nanometer-sized magnetic particles have been intensively investigated due to 
their particularly large surface:volume ratio, quantum-size effect, magnetic character 
as well as their potential application in the areas of bioscience and medicine. Very 
promising nanoparticles are magnetic iron oxide (Fe3O4) nanoparticles with appropriate 
surface modification, which have been widely used experimentally for numerous in 
vivo applications, such as magnetic resonance imaging, tissue repair, immunoassay, 
detoxification of biological fluids, drug delivery, hyperthermia, cell separation, and 
so on.1,2
In our previous studies,3,4 we demonstrated that Fe3O4 magnetic nanoparticles 
(Fe3O4-MNPs) combined with chemotherapy drugs could inhibit tumor proliferation 
and induce apoptosis of tumor cells in a dose- and time-dependent manner, which 
may be related to the change in drug formulations caused by magnetic nanomaterials. 
As a targeted therapeutic drug agent for malignant tumor due to its high specificity, 
Fe3O4-MNPs may become the mainstay for tumor-targeted therapy.
So far, clinical application of magnetic nanoparticles has focused mainly on the 
areas of magnetic ferrite. Compared with other magnetic materials, magnetic iron International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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oxide nanoparticles (mainly Fe3O4 and gamma-Fe2O3), which 
have good chemical stability, magnetic responsiveness, 
biocompatibility, easy preparation, and significant features 
in the diagnosis and treatment of diseases, have attracted the 
attention of researchers worldwide.
The prospects of extensive application of magnetic nano-
particles, account for their impact on human health, living 
environment, and even life in all aspects of the process are the 
focus of researchers,5,6 and there are high expectations for their 
magnetic   characteristics and lower cytotoxicity. However, the 
risk assessment of the biological safety of magnetic nanopar-
ticles has just started and remains in the initial stage of accu-
mulation of controversial data. As a result of their short period 
of use in human activities, there are few reports on the toxicity 
of nanomaterials.7–9 One   experiment reported that nanosilver 
at a high concentration had a significant cytotoxic effect on the 
healthy human peripheral blood mononuclear cells and sig-
nificantly inhibited the   phytohemagglutinin-induced cytokine 
production.10 Therefore, a safety   evaluation, especially of the 
in vitro and in vivo immunological effects of Fe3O4-MNPs is 
urgently needed.
According to the requirements of the State Drug Admin-
istration in 2002 as stated in ‘Guiding Principles for the 
Chemical and Therapeutic Biological Products Study’,11 
clinical treatment with Fe3O4-MNPs is ,5 days, and the 
experimental period is 14 days. In our study, Fe3O4-MNPs 
were orally administered once as a single dose imprinting 
control region (ICR) mice, and in their general performance 
was observed. Furthermore, all mice were sacrificed sepa-
rately and used to assess splenocyte proliferation, release of 
cytokines, and T-lymphocyte subsets and also to understand 
whether Fe3O4-MNPs are toxic to ICR mice, thus providing 
a basis for its safe use in clinical settings.
Material and method
Animals and animal care
Female and male ICR mice, which were age-matched 
(8 weeks of age) and weight-matched (18–22 g), were pur-
chased from Shanghai National Center for Laboratory Animals. 
The mice were kept in a 12-hour dark/light cycle and received 
water and food ad libitum in a semibarrier system.
Preparation of Fe3O4-MNPs
As previously described,12 Fe3O4-MNPs were produced by 
electrochemical deposition under oxidizing conditions. 
Briefly, a quantity of ferric chloride hexahydrate (0.02 mol/L) 
and ferrous sulfate heptahydrate (0.012 mol/L) was dis-
solved in 200 mL deionized water under nitrogen protection, 
and then about 50 mL of 25% ammonium hydroxide was 
added slowly with violent magnetic force stirring until the 
pH was 9. The procedure took 30 minutes to generate a dark 
precipitate. Next, the resultant preciptate was separated using 
a permanent magnet and then washed repeatedly by deionized 
water 5–7 times until the pH of the supernatant was 7. Finally, 
the characteristics of Fe3O4-MNPs were analyzed.
Determination of Fe3O4-MNPs  
size and zeta potential
To measure the Fe3O4-MNPs particle size, the sample was 
dispersed in deionized water and then the particle size was 
measured using a glass cuvette by the ZetaPlus particle seizer 
(Brookhaven Instruments Corporation, Holtsville, NY). The 
same suspension was used for measuring the zeta potential 
of particles. The average zeta potential and the standard 
deviation of the three analyses were reported.
Analysis of X-ray diffraction patterns
X-ray diffraction (XRD) pattern of lyophilized sample of 
Fe3O4-MNPs was carried out using an X-ray diffractometer 
(ARL X’TRA; Thermo Electron Co, Ecublens, Switzerland). 
The equipment used a copper target X-ray tube with Cu Kα 
radiation at a scan speed of 5°/minute. The acceleration volt-
age and the current flux chosen for the measurement were 
45 kV and 35 mA, respectively.
experimental groups
Forty ICR mice, half male and half female, were individually 
and randomly divided into four groups: control group (0.5 mL 
of sterile physiologic saline), low-dose group (300 mg/kg Fe3O4-
MNPs), medium-dose group (600 mg/kg Fe3O4-MNPs), and 
high-dose group (1200 mg/kg Fe3O4-MNPs). The mice in the 
exposed group were given different concentrations of Fe3O4-
MNPs, and those in the control group were given RPMI-1640 
(Gibco Chemical Co, Carlsbad, CA) medium by single gastric 
perfusion and observed for the poisoning symptoms after 
administration of the drug; finally, they were all sacrificed under 
Avertin anesthesia by cervical dislocation after 14 days and 
used to measure various immune indicators.
Preparation of blood samples
Blood samples were obtained from ICR mice by extirpated 
eyeballs after being exposed for 14 days. Blood was centri-
fuged (1500 rpm) for 5 minutes at 4°C to separate plasma 
from blood cells. The blood mononuclear cells were used for 
analyzing surface markers of T lymphocytes, and the plasma 
was prepared for quantitative determination of cytokines.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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MTT assays for splenocyte proliferation
Single-cell suspensions were prepared aseptically from ICR 
mice spleens in RPMI-1640 medium. Briefly, a single-cell 
suspension was prepared by puncturing the spleen with a 
20-gauge needle and gently flushing the organ with ice-cooled 
(4°C) RPMI-1640. The remaining splenocyte suspension, 
which was freed from debris by centrifugation at 1000 rmp for 
20 minutes at 4°C, was washed twice and adjusted to 2 × 106 
cells/mL with RPMI-1640. The adjusted cells were placed 
in a 96-well microtiter plate in 200 µL aliquots and cultured 
in the presence of T-lymphocytes mitogen (5 µg/mL Con-
canavalin A [ConA]) (Sigma Chemical Co, St. Louis, MO) 
for 68 hours at 37°C in a 5% humidified CO2 atmosphere. 
The cells that received complete RPMI-1640 medium in the 
place of mitogen were regarded as the control group. Follow-
ing this, 10 µL 3-2 (4, 5-dimethylthiazol-2-yl) 2, 5-diphe-
nyltetrazolium bromide (MTT) (0.5 mg/mL) (Pharmingen, 
San Diego, CA) was added to each well and cultured for 
another 4 hours. The formazan was dissolved with 150 µL 
dimethyl sulfoxide after blotting the culture medium. The 
plates were shaken lightly for 10 minutes, and then the reduc-
tion of methyl thiazol tetrazolium (MTT) was quantified by 
absorbance at a wavelength of 570 nm using a microplate 
reader (Model-550; Bio-Rad Laboratories, Hercules, CA). 
The results were expressed as a mean differential stimulate 
index (SI) (SI = optical density with ConA/optical density 
without ConA) of each animal.
eLIsA assays for quantitative 
determination of cytokines
The release of interleukin 2 (IL-2), interleukin 4 (IL-4), 
interleukin 10 (IL-10), and interferon-γ (INF-γ) in serum 
were measured in duplicate using enzyme-linked immuno-
sorbent assay (ELISA) kit (Gibco, Carlsbad, CA) according 
to the manufacturer’s instructions. Briefly, 50 µL samples or 
standard control was added to 50 µL assay diluents in each 
well, incubated at room temperature for 2 hours, and after 
thorough washing, 100 µL conjugate was added to each 
well for incubation for 2 hours. A 100 µL substrate solution 
was then added to each well and incubated for a further 
30 minutes. Finally, a 100 µL stop solution was added to 
each well, and the optical density was measured using an 
ELISA reader (Bio-Rad Laboratories) with dual wavelength 
of 450 nm.
FcM assays for T-lymphocyte subsets
Phenotypic analyses of blood lymphocytes were per-
formed using flow cytometry. Briefly, blood mononuclear 
cells were separated on Ficoll-Hypaque, washed twice in 
phosphate-buffered saline (PBS), and adjusted to a density 
of 1 × 107 cells/mL. The cells were incubated with PE or 
FITC-conjugated monoclonal antibodies (antimouse CD3 
[PE-Cy5], antimouse CD4 [FITC], or antimouse CD8 [PE]) 
(all sourced from Pharmingen) for 10 minutes, washed three 
times, and resuspended in PBS immediately before deter-
mination. At least 10,000 cells in fluorescent channel 3 for 
CD3, fluorescent channel 1 for CD4, and fluorescent channel 
2 for CD8 were detected using FACScan flow cytometer 
(Becton Dickinson, Franklin Lakes, NJ) and analyzed with 
CELLQuest. Results were expressed as mean fluorescence 
intensity for a given molecule per cell.
statistical analysis
Data were expressed as means ± standard deviation (x ± S) 
Statistical analyses were done using SAS software (version 
9.1; SAS Institute, Cary, NC). One-way analysis of variance 
(ANOVA) and rank sum test were carried out to compare 
the normal data distribution between the exposed and control 
groups. Wilcoxon rank test was carried out to compare the 
nonnormal data distribution between the exposed and control 
groups. Statistical significance for all tests was P = 0.05.
Results
Physical characteristics of magnetic 
nanoparticles
The particle size of the analyzer showed that the size of 
Fe3O4-MNPs ranged from 20.3 to 95.5 nm and the median 
particle size was 44.0 nm (Figure 1). The zeta potential of 
Fe3O4-MNPs in water was −24.71 mV .
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Figure 1 Particle size of Fe3O4-MNPs.
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XRD pattern of prepared Fe3O4-MNPs reveal diffraction 
peaks at (111), (220), (311), (400), (422), (511), (440), and 
(533), which are the characteristic peaks of the Fe3O4 crystal 
with a cubic spinel structure (Figure 2).
splenocytes proliferation
Wilcoxon rank test was carried out to compare the data of 
splenocyte proliferation from the ICR mice in the groups 
fed with a different dose of Fe3O4-MNPs, which were not 
subject to the normal distribution. Our results showed that 
there was no significant difference in SI between the exposed 
and control groups (P . 0.05) (Figure 3).
The level of serum cytokine in Icr mice
With the exception of  INF-γ, the data on cytokine production 
from the ICR mice in these four groups fed with a different 
doses of Fe3O4-MNPs showed a normal distribution. One-way 
ANOVA and rank sum test were carried out to compare the 
data on IL-2, IL-4, and IL-10 production between the exposed 
and control groups. Wilcoxon rank test was carried out to 
compare the data on INF-γ production between the exposed 
and control groups. We found that the various differences of 
cytokine production from the ICR mice were not statistically 
significant in the four groups fed with a different dose of Fe3O4-
MNPs (Table 1).
T-lymphocyte subsets
A Wilcoxon rank test was carried out to compare the data of 
T-lymphocyte subsets from the ICR mice in the four groups 
fed with a different dose of Fe3O4-MNPs, which were not 
subject to a normal distribution. We found that there was 
no difference between the low-dose group and the control 
group in the proportion of CD3+CD4+ and CD3+CD8+   
T lymphocytes in peripheral blood of ICR mice (P . 0.05), 
but a greater proportion of CD3+CD4+ and CD3+CD8+ 
T   lymphocytes in peripheral blood of ICR mice was detected 
in both the medium- and high-dose groups than the control 
group (P , 0.05) (Table 2).
Discussion
Fe3O4-MNPs with excellent properties have been suc-
cessfully prepared by electrochemical deposition under 
oxidizing conditions and confirmed by XRD. The positions 
of the characteristic peaks agreed well with Joint Commit-
tee on Powder Diffraction Standards (JCPDS) card (No. 
19-0629), which showed that the product is in the pure Fe3O4 
phase and that there are no other detectable phases. Based 
on the characteristics of prepared Fe3O4-MNPs, they can be 
used to study its effect on the immune function in vivo.
Splenic lymphocytes contain T lymphocytes and 
B   lymphocytes, and both contents are approximate. ConA is 
a mitogen of T lymphocytes, which promotes the   proliferation 
of only T lymphocytes, and lipopolysaccharides is a   mitogen 
of B lymphocytes, which promotes the proliferation of 
only B lymphocytes. Lymphocytes proliferation is the most 
direct reflection of the cellular immunity. T lymphocytes and 
B   lymphocytes stimulated by antigens can split and   proliferate,   
resulting in a specific immune response and producing anti-
bodies or cytokines. Therefore, we have investigated spleno-
cyte proliferation of ICR mice fed with a   different dose of 
Fe3O4-MNPs, following exposure to ConA.
T lymphocytes include three major functional subsets: 
T-helper lymphocytes (Th cells), T-suppresser lymphocytes 
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Figure 2 The crystallinity of Fe3O4-MNPs by XrD.
Abbreviations: Fe3O4-MNPs, Fe3O4 magnetic nanoparticles; XrD, X-ray diffraction.
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Figure 3 splenocytes proliferation of Icr mice fed with different doses of Fe3O4-
MNPs. 
Notes: A control group, B low-dose group (300 mg/kg Fe3O4-MNPs), C medium-
dose group (600 mg/kg Fe3O4-MNPs), D high-dose group (1200 mg/kg Fe3O4-MNPs),   
*P . 0.05, there were no difference between exposed groups and control group.
Abbreviations: Fe3O4-MNPs, magnetic Fe3O4 nanoparticles; Icr, imprinting control 
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(Ts cells), and T-cytotoxic lymphocytes (Tc cells). Th cells 
express CD3+CD4+, but Ts cells and Tc cells express CD3+CD8+. 
CD3+CD4+ cells can secrete various cytokines and play an 
important role in regulating the body’s immune response. 
Th1 cells secrete interleukins such as IL-2 and INF-γ, whose 
main   function is to promote cell-mediated immune response; 
they are involved in proliferation, differentiation, and matu-
rity in late hypersensitivity reacting T cells and cytotoxic T 
  lymphocytes. They can also activate macrophages and natural 
killer cells. Th2 cells secrete interleukins such as IL-4 and 
IL-10, which can induce not only the humoral immune mecha-
nism but also the specific   cellular immune responses through 
other ways. Under normal   circumstances, Th1/Th2 maintain a 
balance in the human body, and their imbalance will lead to 
many diseases.13
We chose IL-2 and IL-4, which reflect Th1 cells’ function, 
and IL-10 and INF-γ, which reflect Th2 cells’ functions, as 
our study subjects. With the exception of  INF-γ, the quanti-
tative determination of serum cytokines from the ICR mice 
fed with a different dose of Fe3O4-MNPs showed a normal 
distribution.
Our results showed that there were no significant changes 
in the level of IL-2, IL-4, IL-10, and  INF-γ in ICR mice fed 
with Fe3O4-MNPs when compared with the control group 
(Table 1). However, a recent study of Liu et al14 reported that 
100 μL Fe3O4 nanoparticles absorbed autovaccine suspension 
(2 mg/mL) were subcutaneously injected into H22 live cancer 
mice, the mass IL-4 inhibitory rate of  mice H22 live cancer 
was raised, the activity of cytotoxicity was boosted, the level 
of INF-γ cytokine was enhanced, and the amount of IL-4 was 
downregulated, which indicates that Fe3O4 nanoparticles as 
adjuvants had great potential to enhance antitumor immune 
response. Our different results may be related to the different 
manner and dosage of drug administration.
Previous studies on the toxicity of iron nanoparticles 
reported that high doses of iron nanoparticles not only cause 
tissue damage, but also elevate the levels of white blood cell 
count.15 A possible explanation for the mechanism of tissue 
damage could be that large doses of iron nanoparticles cause 
tissue damage, which then induces cytotoxicity, leading to 
an inflammatory reaction, eventually causing the change of 
T-lymphocyte subsets.
Our recent article indicates that the proportion of CD4+ 
and CD8+ T-lymphocytes subset in the peripheral blood of 
the low-dose group was more than that of the control group 
in ICR mice, though there was no difference in the number 
of CD4+ T cells between the medium-dose group and the 
low-dose group. Interestingly, the Fe3O4-MNPs altered the 
production of IL-2, INF-γ, and IL-10, but no significant 
changes of IL-4 were observed in peripheral blood. Therefore, 
it is concluded that Fe3O4-MNPs could influence immune 
functions of normal ICR mice in a dose-dependent manner.16 
Table 2 The proportion of T-lymphocyte subsets of Icr mice fed with different doses of Fe3O4-MNPs (n = 10, x ± S)
T lymphocytes
Groups (%)
Control group Low dose of 
Fe3O4-MNPs
Medium dose of 
Fe3O4-MNPs 
High dose of 
Fe3O4-MNPs
cD3+cD4+ 46.01 ± 4.02 40.61 ± 4.04 59.15 ± 1.59* 59.66 ± 1.84*
cD3+cD8+ 20.42 ± 0.28 22.14 ± 0.60 23.24 ± 0.54** 23.40 ± 1.77**
Notes: *P , 0.05 versus control group by Wilcoxon rank test; **P , 0.05 versus control group by Wilcoxon rank test.
Abbreviations: Fe3O4-MNPs, Fe3O4 magnetic nanoparticles; Icr, imprinting control region.
Table 1 The level of serum cytokine in Icr mice fed with Fe3O4-MNPs
Groups The level of cytokines (pg/mL) (n = 10, x ± S)
IL-2 IL-4 IL-10 INF-γ
control 29.97 ± 1.93 28.90 ± 1.92 28.31 ± 1.51 11.55 ± 3.55
Low dose  
of Fe3O4-MNPs
30.23 ± 3.02* 29.18 ± 2.45** 29.70 ± 1.56*** 13.15 ± 1.29****
Medium dose  
of Fe3O4-MNPs
29.28 ± 1.14* 28.14 ± 0.67** 29.03 ± 2.66*** 12.79 ± 1.87****
high dose  
of Fe3O4-MNPs
29.00 ± 1.21* 27.78 ± 1.55** 29.27 ± 3.34*** 12.57 ± 2.71****
Notes: *P . 0.05, **P . 0.05, ***P . 0.05 versus control group by one-way analysis of variance (ANOVA) and rank sum test; ****P . 0.05 versus control group by Wilcoxon 
rank test.
Abbreviations: Fe3O4-MNPs, Fe3O4 magnetic nanoparticles; Icr, imprinting control region.International Journal of Nanomedicine
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The results presented in this article are different from these 
of other recent reports, because we have employed the 
method of offering oral Fe3O4-MNPs instead of intravenous   
Fe3O4-MNPs. Oral Fe3O4-MNPs must be affected by the 
acidic environment in the mice’s stomach and absorbed in 
gastrointestinal organs. How to affect the metabolism of   
Fe3O4-MNPs at the molecular level by the actions of stomach 
acidity and gastrointestinal absorption will be investigated 
in our future research.
Conclusions
Based on the characteristics and the effects of Fe3O4-MNPs 
on splenocyte proliferation, cytokine production, and   
T-lymphocyte subsets in ICR mice, our studies conclude 
that a high dose of Fe3O4-MNPs could influence in vivo 
immune function of normal ICR mice. However, the reasons 
why there are changes in splenocyte proliferation, cytokine 
production, and T-lymphocyte subsets in ICR mice fed with 
high dose of Fe3O4-MNPs need to be further explored. 
  Moreover, subacute and chronic toxicity of Fe3O4-MNPs 
in vivo still need to be further explored in the future.
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